Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

156
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 09:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Latest news on GLAXOSMITHKLINE PLC
6h ago GLAXOSMITHKLINE : introduces Incruse Ellipta in UK for COPD patients
8h ago GLAXOSMITHKLINE : Assigned Patent
9h ago Regus forecasts capex below estimates, eases fears over debt
1d ago GLAXOSMITHKLINE : Project HOPE and the North Carolina GlaxoSmithKline Foundation..
2d ago Company focus: glaxosmithkline (focus)
3d ago Sanofi shares sink as diabetes sales slow, CEO pressured
3d ago GLAXOSMITHKLINE : *kepler cheuvreux raises glaxosmithkline price target to 1540 ..
3d ago GLAXOSMITHKLINE : China's legal renaissance sounds death knell for Guanxi
3d ago Novartis results top forecasts as new products gain momentum
4d ago GLAXOSMITHKLINE : Publication of Supplementary Prospectus
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF